Name: Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End Use Industry, Health/Functional Positioning, Distribution Channel, and Region – Global Forecast to 2031
Brand: MarketsandMarkets
SKU: FB10562
Price: 4950 USD
Availability: InStock

報告摘要

The precision biotics market is estimated to record USD 4.91 billion in 2026 and reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031. “Gut & brain segment is driving market growth due to the rising focus on the gut-brain axis and personalized mental wellness solutions” The gut & brain sub-segment under health/functional positioning is expected to witness the fastest growth in the precision biotics market owing to the growing awareness about the gut-brain axis and rising cases of stress, anxiety, depression, and other mental conditions. The ongoing developments in microbiome science, growing scientific evidence of the impact of gut microbiota on brain function, and the need for tailored solutions for improving mental wellness are leading to the rising use of precision biotics for gut and brain health. “E-commerce is driving market growth through expanding online retail and digital health platforms” E-commerce is expected to become the fastest-growing route for distribution within the precision biotics market owing to the rising online purchasing trends and consumers' growing inclination toward easily available precision biotics products online. The development of online pharmacies, health and wellness platforms, as well as personalized offerings and recommendations, makes precision biotics more readily available, while competitive prices, broad product availability, and delivery at home keep boosting sales online. “North America is expected to hold a significant share in the global precision biotics market owing to its advanced microbiome research ecosystem & strong industry presence” North America holds the major share in the precision biotics market owing to the well-developed research ecosystem for microbiome, the presence of prominent precision biotics firms, and the use of personalized nutrition and preventive healthcare. Some other factors that contribute to the success of North America include the established healthcare infrastructure, rising awareness among consumers about gut health, innovations in microbiome, and access to clinically tested precision biotics. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Precision Biotics market. • By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45% • By Designation: CXOs – 25%, Managers – 35%, Others – 40% • By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, and Rest of the World – 5% Prominent companies in the market include BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)- (Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and others. Research Coverage This research report categorizes the precision biotics market by type (precision probiotics, next generation probiotics (NGPs), synbiotics, postbiotics), end-use industry (dietary supplements, functional food & beverages, pet supplements, pharmaceutical (OTC), infant formula, cosmetics, animal feed), health/functional positioning (digestive & gastrointestinal health, women's health, pediatric & infant health, skin health, gut & brain health, metabolic health, immune health, oral & dental health), distribution channel (pharmacies, retail, specialty stores, e-commerce, DTC subscription platforms), and region (North America, Europe, Asia Pacific, Rest of the World). The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Precision Biotics industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the Precision Biotics market. This report provides a competitive analysis of emerging startups in the Precision Biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others. Reasons to Buy This Report The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall precision biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (Growing Adoption of Personalized & Targeted Nutrition and Microbiome-based Healthcare, Growing Incidence of Gastrointestinal Disorders), restraints (High Development Costs of Strain-Specific Precision Biotics, Complex Regulatory Pathways for Personalized Microbiome Products), opportunities (Increasing Partnerships Between Biotech Firms and Healthcare Providers, Rising Demand for Precision Nutrition in Chronic Disease Management), and challenges (Ensuring Strain Stability and Product Quality Across Supply Chains, Need for Robust Clinical Evidence to Support Health Claims) • Product Development/Innovation: Detailed insights into research & development activities and product launches in the precision biotics market • Market Development: Comprehensive information about lucrative markets—analysis of precision biotics across varied regions • Market Diversification: Exhaustive information about product sources, untapped geographies, recent developments, and investments in the precision biotics market • Competitive Assessment: In depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Darling Ingredients (US), Tessenderlo Group (Belgium) - BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and other players in the precision biotics market.

目錄 Table of Contents

1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE AND SEGMENTATION 28 1.3.1 YEARS CONSIDERED 30 1.3.2 CURRENCY CONSIDERED 30 1.3.3 UNIT CONSIDERED 31 1.4 STAKEHOLDERS 31 2 EXECUTIVE SUMMARY 33 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 33 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 34 2.3 DISRUPTIVE TRENDS IN PRECISION BIOTICS MARKET 35 2.4 HIGH-GROWTH SEGMENTS 36 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 37 3 PREMIUM INSIGHTS 39 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION BIOTICS MARKET 39 3.2 PRECISION BIOTICS MARKET, BY TYPE AND REGION 40 3.3 PRECISION BIOTICS MARKET, BY TOP THREE TYPES 40 3.4 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL 41 3.5 PRECISION BIOTICS MARKET, BY TOP FOUR HEALTH/ FUNCTIONAL POSITIONINGS 41 3.6 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY 42 3.7 PRECISION BIOTICS MARKET, BY COUNTRY 42 4 MARKET OVERVIEW 43 4.1 INTRODUCTION 43 4.2 MARKET DYNAMICS 44 4.2.1 DRIVERS 44 4.2.1.1 Growing adoption of personalized & targeted nutrition and microbiome-based healthcare 44 4.2.1.2 Growing incidence of gastrointestinal disorders 45 4.2.1.3 Growing consumer focus on preventive healthcare 46 4.2.2 RESTRAINTS 46 4.2.2.1 High development costs of strain-specific precision biotics 46 4.2.2.2 Complex regulatory pathways for personalized microbiome products 47 4.2.3 OPPORTUNITIES 48 4.2.3.1 Increasing partnerships between biotech firms and healthcare providers 48 4.2.3.2 Rising demand for precision nutrition in chronic disease management 48 4.2.3.3 Growing integration of AI and multi-omics technologies in product development & advancement in the microbiome sequencing 49 4.2.4 CHALLENGES 50 4.2.4.1 Ensuring strain stability and product quality across supply chains 50 4.2.4.2 Need for robust clinical evidence to support health claims 51 4.3 UNMET NEEDS AND WHITE SPACES 51 4.3.1 UNMET NEEDS IN PRECISION BIOTICS MARKET 51 4.3.2 WHITE SPACE OPPORTUNITIES 52 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53 4.4.1 INTERCONNECTED MARKETS 53 4.4.2 CROSS-SECTOR OPPORTUNITIES 53 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 54 4.5.1 KEY MOVES AND STRATEGIC FOCUS 54 5 INDUSTRY TRENDS 55 5.1 PORTER’S FIVE FORCES ANALYSIS 55 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 56 5.1.2 BARGAINING POWER OF SUPPLIERS 56 5.1.3 BARGAINING POWER OF BUYERS 56 5.1.4 THREAT OF SUBSTITUTES 57 5.1.5 THREAT OF NEW ENTRANTS 57 5.2 MACROECONOMIC OUTLOOK 57 5.2.1 INTRODUCTION 57 5.2.2 MACROECONOMIC INDICATORS 57 5.2.2.1 Aging demographics fuel growth of north american probiotics market 57 5.2.2.2 Increasing national healthcare expenditure 58 5.2.2.3 Increasing prevalence of lifestyle-related chronic disorders 59 5.3 VALUE CHAIN ANALYSIS 59 5.3.1 RESEARCH & CONSUMER PRODUCT DEVELOPMENT 60 5.3.2 INGREDIENT SOURCING & STRAIN DEVELOPMENT 60 5.3.3 MANUFACTURING & PRODUCT FORMULATION 60 5.3.4 DISTRIBUTION, RETAIL & SUPPLY CHAIN MANAGEMENT 61 5.3.5 CONSUMER APPLICATIONS & COMMERCIALIZATION 61 5.4 ECOSYSTEM/MARKET MAP ANALYSES 61 5.4.1 DEMAND SIDE 61 5.4.2 SUPPLY SIDE 62 5.5 PRICING ANALYSIS 63 5.5.1 INTRODUCTION 63 5.5.2 INDICATIVE PRICE TREND AMONG MARKET PLAYERS 64 5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION 64 5.5.4 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS) 65 5.6 TRADE ANALYSIS 66 5.6.1 IMPORT ANALYSIS: PRECISION BIOTICS 67 5.6.2 EXPORT ANALYSIS: PRECISION BIOTICS 68 5.7 KEY CONFERENCES AND EVENTS, 2026–2027 68 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69 5.9 INVESTMENT AND FUNDING SCENARIO 69 5.10 CASE STUDY ANALYSIS 70 5.10.1 PENDULUM – LAUNCH OF PENDULUM GLUCOSE CONTROL FOR PRECISION BLOOD SUGAR MANAGEMENT 70 5.10.2 BIOGAIA – LAUNCH OF BIOGAIA PROTECTIS PLUS NEXT-GENERATION PATENTED PROBIOTIC DROPS 71 5.10.3 FLORÉ (SUN GENOMICS) – DEVELOPMENT OF PRECISION SYNBIOTICS FOR AUTISM SPECTRUM DISORDER SUPPORT 71 5.10.4 VIOME – LAUNCH OF VRX MY·BIOTICS TOOTHPASTE & GEL FOR PERSONALIZED ORAL MICROBIOME HEALTH 72 5.11 IMPACT OF 2025 US TARIFF –PRECISION BIOTICS MARKET 73 5.11.1 INTRODUCTION 73 5.11.2 PRICE IMPACT ANALYSIS 74 5.11.3 IMPACT ON COUNTRIES/REGIONS 74 5.11.3.1 US 74 5.11.3.2 Europe 74 5.11.3.3 Asia Pacific 74 5.11.4 IMPACT ON END USE INDUSTRIES 75 6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 76 6.1 TECHNOLOGY ANALYSIS 76 6.1.1 KEY TECHNOLOGIES 76 6.1.1.1 Next-generation sequencing (NGS) 76 6.1.1.2 Precision fermentation & strain engineering 76 6.1.2 COMPLEMENTARY ANALYSIS 77 6.1.2.1 Microencapsulation & controlled release delivery systems 77 6.1.2.2 Synbiotic formulation technologies 77 6.1.3 ADJACENT TECHNOLOGIES 78 6.1.3.1 Bioprocess automation & smart manufacturing 78 6.1.3.2 Metabolomics platforms 78 6.2 PATENT ANALYSIS 79 6.3 FUTURE APPLICATIONS 81 6.3.1 SMART (DISEASE-SENSING) PROBIOTICS: ENABLING THE NEXT GENERATION OF PRECISION BIOTICS 82 6.3.2 ENGINEERED LIVE BIOTHERAPEUTICS: SHAPING THE FUTURE OF PRECISION BIOTICS 82 6.3.3 ENGINEERED PRECISION PROBIOTICS FOR INFLAMMATORY BOWEL DISEASE (IBD): ADVANCING TARGETED MICROBIOME THERAPEUTICS 83 6.3.4 POSTBIOTICS FOR NEXT-GENERATION FUNCTIONAL FOODS AND BIOPRESERVATION 83 6.4 IMPACT OF GENERATIVE AI ON PRECISION BIOTICS MARKET 84 6.4.1 INTRODUCTION 84 6.4.2 TOP USE CASES AND MARKET POTENTIAL 84 6.4.3 BEST PRACTICES IN PRECISION BIOTICS INDUSTRY 84 6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN THE PRECISION BIOTICS MARKET 85 6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 85 6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR PRECISION BIOTICS 86 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 86 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 87 7.1 REGIONAL REGULATIONS AND COMPLIANCE 87 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 7.1.2 INDUSTRY STANDARDS 90 7.1.3 LABELING REQUIREMENTS AND CLAIMS 92 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 93 7.1.4.1 Enhanced strain traceability and clinical evidence requirements 93 7.1.4.2 Global harmonization of precision biotics regulations 93 7.1.4.3 Stricter clinical validation and health claim compliance 93 7.1.4.4 Digital traceability, AI-enabled quality monitoring, and compliance automation 93 7.1.4.5 Higher quality standards for live biotherapeutic and next-generation biotics 93 7.2 SUSTAINABILITY INITIATIVES 93 7.2.1 SUSTAINABLE SOURCING 94 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 94 7.2.3 CIRCULAR ECONOMY APPROACHES 95 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 95 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 96 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 97 8.1 DECISION-MAKING PROCESS 97 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 98 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 98 8.2.2 BUYING CRITERIA 99 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 100 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 101 8.5 MARKET PROFITABILITY 103 8.6 REVENUE POTENTIAL 103 8.6.1 COST DYNAMICS 103 8.6.2 MARGIN OPPORTUNITIES, BY TYPE 105 9 PRECISION BIOTICS MARKET, BY TYPE 106 9.1 INTRODUCTION 107 9.2 PRECISION PROBIOTICS 109 9.2.1 PRECISION PROBIOTICS TO FUEL EXPANSION OF PRECISION BIOTICS MARKET 109 9.3 NEXT-GENERATION PROBIOTICS 110 9.3.1 NEXT-GENERATION PROBIOTICS DRIVING INNOVATION IN PRECISION BIOTICS MARKET 110 9.4 SYNBIOTICS 112 9.4.1 PERSONALIZED SYNBIOTICS DRIVING INNOVATION AND GROWTH IN PRECISION BIOTICS MARKET 112 9.5 POSTBIOTICS 114 9.5.1 COMMERCIALIZATION OF POSTBIOTIC PRODUCTS STRENGTHENING PRECISION BIOTICS MARKET 114 10 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY 116 10.1 INTRODUCTION 117 10.2 DIETARY SUPPLEMENTS 118 10.2.1 GROWING DIETARY SUPPLEMENT ADOPTION DRIVING GLOBAL PRECISION BIOTICS GROWTH 118 10.3 FUNCTIONAL FOOD & BEVERAGES 119 10.3.1 GROWING DEMAND FOR FUNCTIONAL FOODS DRIVING PRECISION BIOTICS ADOPTION 119 10.4 PET SUPPLEMENTS 121 10.4.1 RISING PET HUMANIZATION DRIVING PRECISION BIOTICS ADOPTION IN COMPANION ANIMAL NUTRITION 121 10.5 PHARMACEUTICALS (OTC) 122 10.5.1 GROWING OTC SELF-CARE TRENDS ACCELERATING PRECISION BIOTICS ADOPTION 122 10.6 INFANT FORMULA 123 10.6.1 EARLY-LIFE NUTRITION INNOVATION DRIVING PRECISION BIOTICS ADOPTION IN INFANT FORMULA 123 10.7 COSMETICS 124 10.7.1 GROWING INVESTMENT IN MICROBIOME-BASED BEAUTY DRIVING PRECISION BIOTICS ADOPTION 124 10.8 ANIMAL FEED 125 10.8.1 SUSTAINABLE ANIMAL NUTRITION DRIVING PRECISION BIOTICS ADOPTION 125 11 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL 126 11.1 INTRODUCTION 127 11.2 PHARMACIES 128 11.2.1 PHARMACIES ACCELERATING ADOPTION OF PRECISION BIOTICS ACROSS GLOBE 128 11.3 RETAIL 130 11.3.1 EXPANDING ORGANIZED RETAIL NETWORKS STRENGTHEN CONSUMER ACCESS TO PRECISION BIOTICS 130 11.4 SPECIALTY STORES 131 11.4.1 SPECIALTY HEALTH STORES ENHANCE CONSUMER ACCESS TO PRECISION BIOTICS GLOBALLY 131 11.5 E-COMMERCE 132 11.5.1 EXPANDING E-COMMERCE PLATFORMS ACCELERATE PRECISION BIOTICS ADOPTION GLOBALLY 132 11.6 DTC SUBSCRIPTION PLATFORMS 133 11.6.1 DIRECT-TO-CONSUMER (DTC) SUBSCRIPTION PLATFORMS EXPAND GLOBAL PRECISION BIOTICS ACCESSIBILITY 133 12 PRECISION BIOTICS MARKET, BY HEALTH/ FUNCTIONAL POSITIONING 135 12.1 INTRODUCTION 136 12.2 DIGESTIVE & GASTROINTESTINAL HEALTH 137 12.2.1 MICROBIOME-BASED DIGESTIVE & GASTROINTESTINAL HEALTH SOLUTIONS ACCELERATING MARKET GROWTH 137 12.3 WOMEN’S HEALTH 139 12.3.1 ADVANCING WOMEN'S HEALTH THROUGH PRECISION MICROBIOME INNOVATION 139 12.4 PEDIATRIC & INFANT HEALTH 140 12.4.1 PEDIATRIC & INFANT HEALTH DRIVING GROWTH OF PRECISION BIOTICS MARKET 140 12.5 SKIN HEALTH 141 12.5.1 GROWING BURDEN OF SKIN DISORDERS DRIVING GLOBAL PRECISION BIOTICS ADOPTION 141 12.6 GUT & BRAIN HEALTH 142 12.6.1 GROWING MENTAL HEALTH BURDEN ACCELERATING PRECISION BIOTICS ADOPTION THROUGH GUT–BRAIN AXIS 142 12.7 METABOLIC HEALTH 143 12.7.1 GROWING BURDEN OF DIABETES AND PREDIABETES ACCELERATING PRECISION BIOTICS ADOPTION 143 12.8 IMMUNE HEALTH 144 12.8.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION 144 12.9 ORAL & DENTAL HEALTH 145 12.9.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION 145 13 PRECISION BIOTICS MARKET, BY REGION 147 13.1 INTRODUCTION 148 13.2 NORTH AMERICA 150 13.2.1 US 155 13.2.1.1 Growing government investments, precision nutrition initiatives, and strategic collaborations driving US precision biotics market 155 13.2.2 CANADA 156 13.2.2.1 Government investments, expanding genomics ecosystem and commercialization programs accelerating Canadian precision biotics market 156 13.3 EUROPE 158 13.3.1 GERMANY 162 13.3.1.1 Precision Biotics Market Driven by Clinical Research and Personalized Nutrition 162 13.3.2 UK 163 13.3.2.1 Increasing Burden of Gastrointestinal Disorders Fueling Precision Biotics Demand 163 13.3.3 FRANCE 164 13.3.3.1 Growing Consumer Awareness and Personalized Nutrition Supporting Precision Biotics 164 13.3.4 ITALY 165 13.3.4.1 Strong Dietary Supplement Adoption Accelerates Precision Biotics Market Growth in Italy 165 13.3.5 SPAIN 167 13.3.5.1 Growing precision medicine and microbiome research drive Spain's precision biotics market 167 13.3.6 REST OF EUROPE 168 13.4 ASIA PACIFIC 169 13.4.1 CHINA 175 13.4.1.1 Expanding nutritional supplements industry accelerating precision biotics adoption in China 175 13.4.2 INDIA 176 13.4.2.1 Rising consumer awareness of gut health and preventive healthcare drives precision biotics market growth 176 13.4.3 JAPAN 177 13.4.3.1 Growing pharmaceutical investments support Japan's precision biotics market 177 13.4.4 AUSTRALIA & NEW ZEALAND 178 13.4.4.1 Advanced life sciences research and preventive healthcare drive the Australia & New Zealand precision biotics market 178 13.4.5 REST OF ASIA PACIFIC 179 13.5 REST OF THE WORLD (ROW) 180 13.5.1 LATIN AMERICA 184 13.5.1.1 Rising obesity and metabolic disorders drive precision biotics market growth 184 13.5.2 MIDDLE EAST 185 13.5.2.1 Expanding pharmaceutical manufacturing and precision medicine drive precision biotics market growth 185 13.5.3 AFRICA 186 13.5.3.1 Rising awareness of gut health and personalized nutrition supports market growth 186 14 COMPETITIVE LANDSCAPE 188 14.1 OVERVIEW 188 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 188 14.3 REVENUE ANALYSIS, 2023–2025 191 14.4 MARKET SHARE ANALYSIS, 2025 192 14.5 COMPANY VALUATION AND FINANCIAL METRICS 194 14.5.1 COMPANY VALUATION 194 14.5.2 EV/EBITDA 195 14.6 BRAND COMPARISON ANALYSIS, BY TYPE 195 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 197 14.7.1 STARS 197 14.7.2 EMERGING LEADERS 197 14.7.3 PERVASIVE PLAYERS 197 14.7.4 PARTICIPANTS 198 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS 199 14.7.5.1 Regional footprint 200 14.7.5.2 Type footprint 201 14.7.5.3 Function footprint 202 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 202 14.8.1 PROGRESSIVE COMPANIES 202 14.8.2 RESPONSIVE COMPANIES 203 14.8.3 DYNAMIC COMPANIES 203 14.8.4 STARTING BLOCKS 203 14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025 204 14.8.5.1 Detailed list of key startups/SMEs 204 14.8.5.2 Competitive benchmarking of key startups/SMEs 205 14.9 COMPETITIVE SCENARIO AND TRENDS 206 14.9.1 PRODUCT LAUNCHES 206 14.9.2 DEALS 207 15 COMPANY PROFILES 209 15.1 KEY PLAYERS 209 15.1.1 BIOGAIA 209 15.1.1.1 Business overview 209 15.1.1.2 Products/Solutions/Services offered 210 15.1.1.3 Recent developments 211 15.1.1.3.1 Product launches 211 15.1.1.3.2 Deals 211 15.1.1.4 MnM view 212 15.1.1.4.1 Key strengths 212 15.1.1.4.2 Strategic choices 212 15.1.1.4.3 Weaknesses & competitive threats 212 15.1.2 NOVONESIS GROUP 213 15.1.2.1 Business overview 213 15.1.2.2 Products/Solutions/Services offered 214 15.1.2.3 Recent developments 215 15.1.2.3.1 Deals 215 15.1.2.4 MnM view 216 15.1.2.4.1 Key strengths 216 15.1.2.4.2 Strategic choices 216 15.1.2.4.3 Weaknesses & competitive threats 216 15.1.3 PROCTER & GAMBLE 217 15.1.3.1 Business overview 217 15.1.3.2 Products/Solutions/Services offered 218 15.1.3.3 MnM view 219 15.1.3.3.1 Key strengths 219 15.1.3.3.2 Strategic choices 219 15.1.3.3.3 Weaknesses & competitive threats 219 15.1.4 UNILEVER 220 15.1.4.1 Business overview 220 15.1.4.2 Products/Solutions/Services offered 221 15.1.4.3 Recent developments 222 15.1.4.3.1 Product launches 222 15.1.4.4 MnM view 222 15.1.4.4.1 Key strengths 222 15.1.4.4.2 Strategic choices 222 15.1.4.4.3 Weaknesses & competitive threats 222 15.1.5 DSM-FIRMENICH GROUP (CULTURELLE) 223 15.1.5.1 Business overview 223 15.1.5.2 Products/Solutions/Services offered 224 15.1.5.2.1 Deals 225 15.1.5.3 MnM view 226 15.1.5.3.1 Key strengths 226 15.1.5.3.2 Strategic choices 226 15.1.5.3.3 Weaknesses & competitive threats 226 15.1.6 NESTLÉ (NESTLÉ HEALTH SCIENCE) 227 15.1.6.1 Business overview 227 15.1.6.2 Products/Solutions/Services offered 229 15.1.6.3 MnM view 229 15.1.7 METAGENICS, LLC 230 15.1.7.1 Business overview 230 15.1.7.2 Products/Solutions/Services offered 231 15.1.7.3 Recent developments 232 15.1.7.3.1 Deals 232 15.1.7.4 MnM view 232 15.1.8 YAKULT HONSHA CO., LTD. 233 15.1.8.1 Business overview 233 15.1.8.2 Products/Solutions/Services offered 234 15.1.8.3 Recent developments 235 15.1.8.3.1 Product launches 235 15.1.8.4 MnM view 235 15.1.9 DANONE 236 15.1.9.1 Business overview 236 15.1.9.2 Products/Solutions/Services offered 237 15.1.9.3 Recent developments 238 15.1.9.3.1 Deals 238 15.1.9.4 MnM view 238 15.1.10 KANEKA CORPORATION (AB-BIOTICS) 239 15.1.10.1 Business overview 239 15.1.10.2 Products/Solutions/Services offered 240 15.1.10.3 Recent developments 241 15.1.10.3.1 Product launches 241 15.1.10.4 MnM view 241 15.1.11 SYMRISE GROUP (PROBI): BUSINESS OVERVIEW 242 15.1.11.1 Products/Solutions/Services offered 243 15.1.11.2 MnM view 243 15.1.12 JARROW FORMULAS, INC 244 15.1.12.1 Business overview 244 15.1.12.2 Products/Solutions/Services offered 244 15.1.12.3 MnM view 245 15.1.13 PENDULUM 246 15.1.13.1 Business overview 246 15.1.13.2 Products/Solutions/Services offered 246 15.1.13.3 Recent developments 247 15.1.13.3.1 Product launches 247 15.1.13.4 MnM view 247 15.1.14 THE GOOD BUG 248 15.1.14.1 Business overview 248 15.1.14.2 Products/Solutions/Services offered 248 15.1.14.3 MnM view 249 15.1.15 SEED HEALTH INC 250 15.1.15.1 Business overview 250 15.1.15.2 Products/Solutions/Services offered 250 15.1.15.3 MnM view 251 15.2 OTHER PLAYERS 252 15.2.1 INFINANT HEALTH INC. 252 15.2.1.1 Business overview 252 15.2.1.2 Products/Solutions/Services offered 252 15.2.1.3 MnM view 253 15.2.2 VIOME LIFE SCIENCES, INC. 254 15.2.2.1 Business overview 254 15.2.2.2 Products/Solutions/Services offered 254 15.2.2.2.1 Product launches 255 15.2.2.3 MnM view 255 15.2.3 BLACKMORES 256 15.2.3.1 Business overview 256 15.2.3.2 Products/Solutions/Services offered 256 15.2.3.3 MnM view 257 15.2.4 LAYER ORIGIN NUTRITION 258 15.2.4.1 Business overview 258 15.2.4.2 Products/Solutions/Services offered 258 15.2.4.3 Recent developments 259 15.2.4.4 MnM view 259 15.2.5 RESBIOTIC 260 15.2.5.1 Business overview 260 15.2.5.2 Products/Solutions/Services offered 260 15.2.5.3 Recent developments 261 15.2.5.3.1 Product launches 261 15.2.5.4 MnM view 261 15.2.6 FITBIOMICS 262 15.2.7 FLORE INC 263 15.2.8 ZBIOTICS 264 15.2.9 BIOHM TECHNOLOGIES 265 15.2.10 MRO MARYRUTH, LLC. 266 16 RESEARCH METHODOLOGY 267 16.1 RESEARCH DATA 267 16.1.1 SECONDARY DATA 268 16.1.1.1 Key data from secondary sources 268 16.1.2 PRIMARY DATA 269 16.1.2.1 Key data from primary sources 269 16.1.2.2 Breakdown of primary profiles 270 16.1.2.3 Key insights from industry experts 271 16.2 MARKET SIZE ESTIMATION 271 16.2.1 TOP-DOWN APPROACH 272 16.2.2 SUPPLY-SIDE ANALYSIS 273 16.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 274 16.3 DATA TRIANGULATION AND MARKET BREAKUP 275 16.4 RESEARCH ASSUMPTIONS 276 16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 277 17 ADJACENT AND RELATED MARKETS 278 17.1 INTRODUCTION 278 17.2 RESEARCH LIMITATIONS 278 17.3 PROBIOTIC SUPPLEMENTS MARKET 278 17.3.1 MARKET DEFINITION 278 17.3.2 MARKET OVERVIEW 279 17.4 PROBIOTICS MARKET 280 17.4.1 MARKET DEFINITION 280 17.4.2 MARKET OVERVIEW 280 18 APPENDIX 282 18.1 DISCUSSION GUIDE 282 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288 18.3 CUSTOMIZATION OPTIONS 290 18.4 RELATED REPORTS 290 18.5 AUTHOR DETAILS 291

圖表清單 List of Tables & Figures

TABLE 1 INCLUSIONS AND EXCLUSIONS 29 TABLE 2 USD EXCHANGE RATES, 2021–2025 31 TABLE 3 INTERCONNECTED MARKETS 53 TABLE 4 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 56 TABLE 5 PRECISION BIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM) 63 TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 65 TABLE 7 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS) 66 TABLE 8 TOP IMPORTERS OF PRECISION BIOTICS, 2022–2025 (USD) 67 TABLE 9 TOP EXPORTERS OF PRECISION BIOTICS, 2022–2025 (USD) 68 TABLE 10 PRECISION BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 68 TABLE 11 PATENTS PERTAINING TO PRECISION BIOTICS MARKET, 2021–2026 80 TABLE 12 TOP USE CASES AND MARKET POTENTIAL 84 TABLE 13 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 84 TABLE 14 PRECISION BIOTICS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 85 TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 85 TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 20 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 21 INDUSTRY STANDARDS IN PRECISION BIOTICS MARKET 91 TABLE 22 LABELING REQUIREMENTS AND CLAIMS IN PRECISION BIOTICS MARKET 92 TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PRECISION BIOTICS MARKET 96 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 99 TABLE 25 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 100 TABLE 26 UNMET NEEDS IN PRECISION BIOTICS MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 102 TABLE 27 COST DYNAMICS IN PRECISION MARKET 104 TABLE 28 MARGIN OPPORTUNITIES IN PRECISION BIOTICS MARKET, BY TYPE 105 TABLE 29 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 107 TABLE 30 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 108 TABLE 31 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 108 TABLE 32 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 108 TABLE 33 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 109 TABLE 34 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 109 TABLE 35 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 110 TABLE 36 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS) 110 TABLE 37 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 111 TABLE 38 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 111 TABLE 39 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 111 TABLE 40 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS) 112 TABLE 41 SYNBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 112 TABLE 42 SYNBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 113 TABLE 43 SYNBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 113 TABLE 44 SYNBIOTICS MARKET, BY REGION, 2026–2031 (TONS) 113 TABLE 45 POSTBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 114 TABLE 46 POSTBOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 114 TABLE 47 POSTBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 115 TABLE 48 POSTBOTICS MARKET, BY REGION, 2026–2031 (TONS) 115 TABLE 49 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 118 TABLE 50 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 118 TABLE 51 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION) 119 TABLE 52 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION) 119 TABLE 53 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2025 (USD MILLION) 120 TABLE 54 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2026–2031 (USD MILLION) 120 TABLE 55 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION) 121 TABLE 56 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION) 121 TABLE 57 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2022–2025 (USD MILLION) 122 TABLE 58 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2026–2031 (USD MILLION) 122 TABLE 59 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2022–2025 (USD MILLION) 123 TABLE 60 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2026–2031 (USD MILLION) 123 TABLE 61 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2022–2025 (USD MILLION) 124 TABLE 62 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2026–2031 (USD MILLION) 124 TABLE 63 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2022–2025 (USD MILLION) 125 TABLE 64 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2026–2031 (USD MILLION) 125 TABLE 65 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 128 TABLE 66 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 128 TABLE 67 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2022–2025 (USD MILLION) 129 TABLE 68 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2026–2031 (USD MILLION) 129 TABLE 69 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2022–2025 (USD MILLION) 130 TABLE 70 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2026–2031 (USD MILLION) 130 TABLE 71 PRECISION BIOTICS MARKET FROM SPECIALTY STORES, BY REGION, 2022–2025 (USD MILLION) 131 TABLE 72 SPECIALTY STORES: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 132 TABLE 73 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2022–2025 (USD MILLION) 133 TABLE 74 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2026–2031 (USD MILLION) 133 TABLE 75 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2022–2025 (USD MILLION) 134 TABLE 76 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2026–2031 (USD MILLION) 134 TABLE 77 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 137 TABLE 78 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 137 TABLE 79 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2022–2025 (USD MILLION) 138 TABLE 80 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2026–2031 (USD MILLION) 138 TABLE 81 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION, 2022–2025 (USD MILLION) 139 TABLE 82 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION, 2026–2031 (USD MILLION) 139 TABLE 83 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2022–2025 (USD MILLION) 141 TABLE 84 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2026–2031 (USD MILLION) 141 TABLE 85 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2022–2025 (USD MILLION) 142 TABLE 86 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2026–2031 (USD MILLION) 142 TABLE 87 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2022–2025 (USD MILLION) 143 TABLE 88 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2026–2031 (USD MILLION) 143 TABLE 89 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2022–2025 (USD MILLION) 144 TABLE 90 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2026–2031 (USD MILLION) 144 TABLE 91 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2022–2025 (USD MILLION) 145 TABLE 92 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2026–2031 (USD MILLION) 145 TABLE 93 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2022–2025 (USD MILLION) 146 TABLE 94 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2026–2031 (USD MILLION) 146 TABLE 95 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 149 TABLE 96 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 149 TABLE 97 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (TON) 149 TABLE 98 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (TON) 149 TABLE 99 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 151 TABLE 100 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 151 TABLE 101 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 151 TABLE 102 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 151 TABLE 103 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 152 TABLE 104 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 152 TABLE 105 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 152 TABLE 106 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 153 TABLE 107 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 153 TABLE 108 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 154 TABLE 109 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 154 TABLE 110 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 154 TABLE 111 US: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 156 TABLE 112 US: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 156 TABLE 113 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 157 TABLE 114 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 157 TABLE 115 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 158 TABLE 116 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 158 TABLE 117 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 159 TABLE 118 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 159 TABLE 119 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 159 TABLE 120 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 159 TABLE 121 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 160 TABLE 122 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 160 TABLE 123 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 161 TABLE 124 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 161 TABLE 125 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 162 TABLE 126 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 162 TABLE 127 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 163 TABLE 128 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 163 TABLE 129 UK: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 164 TABLE 130 UK: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 164 TABLE 131 FRANCE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 165 TABLE 132 FRANCE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 165 TABLE 133 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 166 TABLE 134 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 166 TABLE 135 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 167 TABLE 136 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 167 TABLE 137 REST OF EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 168 TABLE 138 REST OF EUROPE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 169 TABLE 139 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 170 TABLE 140 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 171 TABLE 141 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 171 TABLE 142 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 171 TABLE 143 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 172 TABLE 144 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 172 TABLE 145 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2022–2025 (USD MILLION) 172 TABLE 146 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2026–2031 (USD MILLION) 173 TABLE 147 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 173 TABLE 148 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 174 TABLE 149 ASIA PACIFIC: PRECISION BIOTICS MARKET, DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 174 TABLE 150 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 174 TABLE 151 CHINA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 175 TABLE 152 CHINA: PRECISION BIOTICS MARKET, BY TYPE 2026–2031 (USD MILLION) 175 TABLE 153 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 176 TABLE 154 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 176 TABLE 155 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 177 TABLE 156 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 178 TABLE 157 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 178 TABLE 158 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 179 TABLE 159 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 179 TABLE 160 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 180 TABLE 161 ROW: PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 180 TABLE 162 ROW: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 181 TABLE 163 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 181 TABLE 164 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 181 TABLE 165 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 181 TABLE 166 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 182 TABLE 167 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 182 TABLE 168 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 182 TABLE 169 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 183 TABLE 170 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 183 TABLE 171 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 184 TABLE 172 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 184 TABLE 173 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 185 TABLE 174 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 185 TABLE 175 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 186 TABLE 176 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 186 TABLE 177 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 187 TABLE 178 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 187 TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY PRECISION BIOTICS MANUFACTURER 188 TABLE 180 PRECISION BIOTICS MARKET: DEGREE OF COMPETITION 193 TABLE 181 PRECISION BIOTICS MARKET: REGIONAL FOOTPRINT, 2025 200 TABLE 182 PRECISION BIOTICS MARKET: TYPE FOOTPRINT, 2025 201 TABLE 183 PRECISION BIOTICS MARKET: FUNCTION FOOTPRINT, 2025 202 TABLE 184 PRECISION BIOTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 204 TABLE 185 PRECISION BIOTIC: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 205 TABLE 186 PRECISION BIOTICS MARKET: PRODUCT LAUNCHES, NOVEMBER 2021–JUNE 2026 206 TABLE 187 PRECISION BIOTICS MARKET: DEALS, NOVEMBER 2021–JUNE 2026 207 TABLE 188 BIOGAIA: COMPANY OVERVIEW 209 TABLE 189 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 210 TABLE 190 BIOGAIA: PRODUCT LAUNCHES 211 TABLE 191 BIOGAIA: DEALS 211 TABLE 192 NOVONESIS GROUP: COMPANY OVERVIEW 213 TABLE 193 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214 TABLE 194 NOVONESIS GROUP: DEALS 215 TABLE 195 PROCTER & GAMBLE (P&G).: COMPANY OVERVIEW 217 TABLE 196 PROCTER & GAMBLE (P&G).: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218 TABLE 197 UNILEVER: COMPANY OVERVIEW 220 TABLE 198 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 221 TABLE 199 UNILEVER: PRODUCT LAUNCHES 222 TABLE 200 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY OVERVIEW 223 TABLE 201 DSM-FIRMENICH GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224 TABLE 202 DSM-FIRMENICH GROUP (CULTURELLE): DEALS 225 TABLE 203 NESTLÉ: COMPANY OVERVIEW 227 TABLE 204 NESTLÉ: PRODUCTS/SOLUTIONS/SERVICES OFFERED 229 TABLE 205 METAGENICS LLC: COMPANY OVERVIEW 230 TABLE 206 METAGENICS LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 231 TABLE 207 METAGENICS LLC: DEALS 232 TABLE 208 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW 233 TABLE 209 YAKULT HONSHA CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 234 TABLE 210 YAKULT HONSHA CO., LTD: PRODUCT LAUNCHES 235 TABLE 211 DANONE: COMPANY OVERVIEW 236 TABLE 212 DANONE.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 237 TABLE 213 DANONE: DEALS 238 TABLE 214 KANEKA CORPORATION (AB-BIOTICS): COMPANY OVERVIEW 239 TABLE 215 KANEKA CORPORATION (AB-BIOTICS): PRODUCTS/SOLUTIONS/SERVICES OFFERED 240 TABLE 216 KANEKA CORPORATION (AB-BIOTICS): PRODUCT LAUNCHES 241 TABLE 217 SYMRISE GROUP (PROBI): COMPANY OVERVIEW 242 TABLE 218 SYMRISE GROUP (PROBI): PRODUCTS/SOLUTIONS/SERVICES OFFERED 243 TABLE 219 JARROW FORMULAS INC: COMPANY OVERVIEW 244 TABLE 220 JARROW FORMULAS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244 TABLE 221 PENDULUM: COMPANY OVERVIEW 246 TABLE 222 PENDULUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 246 TABLE 223 PENDULUM: PRODUCT LAUNCHES 247 TABLE 224 THE GOOD BUG: COMPANY OVERVIEW 248 TABLE 225 THE GOOD BUG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248 TABLE 226 SEED HEALTH INC.: COMPANY OVERVIEW 250 TABLE 227 SEED HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 250 TABLE 228 INFINANT HEALTH INC.: COMPANY OVERVIEW 252 TABLE 229 INFINANT HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252 TABLE 230 VIOME LIFE SCIENCES, INC.: COMPANY OVERVIEW 254 TABLE 231 VIOME LIFE SCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254 TABLE 232 VIOME LIFE SCIENCES, INC: PRODUCT LAUNCHES 255 TABLE 233 BLACKMORES: COMPANY OVERVIEW 256 TABLE 234 BLACKMORES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 256 TABLE 235 LAYER ORIGIN NUTRITION: COMPANY OVERVIEW 258 TABLE 236 LAYER ORIGIN NUTRITION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 258 TABLE 237 RESBIOTIC: COMPANY OVERVIEW 260 TABLE 238 RESBIOTIC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260 TABLE 239 RESTBIOTIC: PRODUCT LAUNCHES 261 TABLE 240 KEY DATA FROM PRIMARY SOURCES 269 TABLE 241 MARKETS ADJACENT TO PRECISION BIOTICS MARKET 278 TABLE 242 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022–2025 (USD MILLION) 279 TABLE 243 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026–2031 (USD MILLION) 279 TABLE 244 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 280 TABLE 245 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 281 FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE 28 FIGURE 2 STUDY YEARS CONSIDERED 30 FIGURE 3 MARKET SCENARIO 33 FIGURE 4 PRECISION BIOTICS MARKET, 2022–2031 (USD BILLION) 34 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PRECISION BIOTICS MARKET, 2022–JUNE 2026 34 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PRECISION BIOTICS MARKET 35 FIGURE 7 PRECISION BIOTICS MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 36 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 37 FIGURE 9 INCREASING CONSUMER FOCUS ON GUT HEALTH AND PREVENTIVE HEALTHCARE TO ACCELERATE GROWTH OPPORTUNITIES IN PRECISION BIOTICS MARKET 39 FIGURE 10 PRECISION PROBIOTICS TYPE SEGMENT AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 40 FIGURE 11 PRECISION PROBIOTICS TYPE SEGMENT TO LEAD MARKET IN 2026 40 FIGURE 12 PHARMACIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 41 FIGURE 13 DIGESTIVE & GASTROINTESTINAL HEALTH SEGMENT TO DOMINATE MARKET IN 2026 41 FIGURE 14 DIETARY SUPPLEMENTS END-USE INDUSTRY SEGMENT TO DOMINATE MARKET IN 2026 42 FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 42 FIGURE 16 PRECISION BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 17 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 55 FIGURE 18 NATIONAL HEALTH EXPENDITURE PER CAPITA IN US FROM 2020 TO 2024 58 FIGURE 19 PRECISION BIOTIC MARKET: VALUE CHAIN ANALYSIS 60 FIGURE 20 PRECISION BIOTICS MARKET ECOSYSTEM MAP 62 FIGURE 21 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 65 FIGURE 22 IMPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD) 66 FIGURE 23 EXPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD) 67 FIGURE 24 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES 69 FIGURE 25 INVESTMENT AND FUNDING SCENARIO 69 FIGURE 26 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026 79 FIGURE 27 FUTURE APPLICATIONS 81 FIGURE 28 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 86 FIGURE 29 PRECISION BIOTICS MARKET DECISION-MAKING FACTORS 97 FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 99 FIGURE 31 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 100 FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES 101 FIGURE 33 PRECISION BIOTICS MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 107 FIGURE 34 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026 VS. 2031 (USD MILLION) 117 FIGURE 35 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026 VS. 2031 (USD MILLION) 127 FIGURE 36 PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2026 VS. 2031 (USD MILLION) 136 FIGURE 37 PRECISION BIOTICS MARKET, BY KEY COUNTRY, 2026–2031 (USD MILLION) 148 FIGURE 38 NORTH AMERICA: PRECISION BIOTICS MARKET SNAPSHOT 150 FIGURE 39 ASIA PACIFIC: PRECISION BIOTICS MARKET SNAPSHOT 170 FIGURE 40 REVENUE ANALYSIS FOR KEY COMPANIES, 2023–2025 (USD BILLION) 191 FIGURE 41 SHARE OF LEADING COMPANIES IN PRECISION BIOTICS MARKET, 2025 192 FIGURE 42 COMPANY VALUATION OF PRECISION BIOTICS MANUFACTURERS, 2025 194 FIGURE 43 EV/EBITDA OF KEY COMPANIES, 2025 195 FIGURE 44 BRAND/PRODUCT/SERVICE ANALYSIS, BY KEY PLAYERS OF PRECISION BIOTICS MARKET 195 FIGURE 45 PRECISION BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 198 FIGURE 46 PRECISION BIOTICS MARKET: COMPANY FOOTPRINT, 2025 199 FIGURE 47 PRECISION BIOTIC MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 203 FIGURE 48 BIOGAIA: COMPANY SNAPSHOT 210 FIGURE 49 NOVONESIS GROUP: COMPANY SNAPSHOT 214 FIGURE 50 PROCTER & GAMBLE (P&G): COMPANY SNAPSHOTS 218 FIGURE 51 UNILEVER: COMPANY SNAPSHOTS 221 FIGURE 52 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY SNAPSHOT 224 FIGURE 53 NESTLÉ: COMPANY SNAPSHOT 228 FIGURE 54 YAKULT HONSHA CO., LTD: COMPANY SNAPSHOT 234 FIGURE 55 DANONE: COMPANY SNAPSHOT 237 FIGURE 56 AB-BIOTICS (SUBSIDIARY OF KANEKA COMPANY): COMPANY SNAPSHOT 239 FIGURE 57 SYMRISE GROUP (PROBI): SNAPSHOT 242 FIGURE 58 PRECISION BIOTICS MARKET: RESEARCH DESIGN 267 FIGURE 59 KEY DATA FROM SECONDARY SOURCES 268 FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 270 FIGURE 61 KEY INSIGHTS FROM INDUSTRY EXPERTS 271 FIGURE 62 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 272 FIGURE 63 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 273 FIGURE 64 PRECISION BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 274 FIGURE 65 DATA TRIANGULATION 275

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End Use Industry, Health/Functional Positioning, Distribution Channel, and Region – Global Forecast to 2031

授權報價

報告摘要

同分類最新報告（食品與飲料）